Clinical Trial

Ablation of Consecutive Atrial Tachycardia

Study acronym: CONCLUDE
Recruiting
View on ClinicalTrials.gov →
Summary
Ablation of consecutive atrial tachycardia (AT) after ablation of atrial fibrillation (AF) or cardiac surgery can be challenging due to complex substrate and AT mechanisms. A substantial portion of patients is known to show various tachycardias and recurrences occur in a noticeable number of cases. With the availability of novel ultra-high-density mapping techniques characterization and understanding of AT mechanisms and underlying substrate can be improved. Aim of this prospective, multi-center, randomized study is to compare a standard AT ablation approach versus minimalized ablation of the clinical AT in regards to arrhythmia free survival.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-02-03; most recent amendment 2026-04-27.
Trial Details
NCT Number NCT05239364
Lead Sponsor Evangelical Hospital Düsseldorf
Conditions Heart Arrhythmia, Heart Diseases, Arrhythmias, Cardiac, Atrial Tachycardia
Enrollment 100 participants
Start Date 2020-12-22
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-30